🇺🇸 FDA
Patent

US 11351231

Lysosomal targeting peptides and uses thereof

granted A61KA61K38/47A61P

Quick answer

US patent 11351231 (Lysosomal targeting peptides and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/47, A61P, A61P3/00, A61P43/00